1-10 of 10
Yulia Nefedova
Close
Sort by
Journal Articles

A Phase 1 Study of Tasquinimod in Patients with Relapsed or Refractory Multiple Myeloma

Dan T. Vogl, MD, Yulia Nefedova, MD PhD, E. Paul Wileyto, PhD, Harjeet Sembhi, Inna Strakovsky, MPH, MRA, Chau Nguyen, Rimzim Taneja, Eva Bondesson, PhD, Helena Eriksson, PhD, Helen Tuvesson, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17–18.
https://doi.org/10.1182/blood-2020-137482
Published: 2020
Journal Articles

A Novel Agent Tasquinimod Demonstrates a Potent Anti-Tumor Activity in Pre-Clinical Models of Multiple Myeloma

Indu R Ramachandran, PhD, Cindy Lin, PhD, Tess Chase, Dmitry Gabrilovich, MD PhD, Yulia Nefedova, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5729.
https://doi.org/10.1182/blood.V124.21.5729.5729
Published: 2014
Journal Articles

Inhibition of Wnt/ß-Catenin Pathway with ICG-001 Induces Apoptosis in Multiple Myeloma.

Eileen R Grigson, MS, Alexandra Pisklakova, MD, Brittany Weissman, Yulia Nefedova, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2951.
https://doi.org/10.1182/blood.V120.21.2951.2951
Published: 2012
Journal Articles

Accumulation of Myeloid-Derived Suppressor Cells in Bone Marrow in Multiple Myeloma Induces Tumor-Specific Immune Suppression and Promotes Tumor Growth

Indu R Ramachandran, PhD, Anna Martner, PhD, Thomas C Condamine, PhD, Alexandra Pisklakova, MD, Tess Chase, Dmitry Gabrilovich, MD, PhD, Yulia Nefedova, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3954.
https://doi.org/10.1182/blood.V120.21.3954.3954
Published: 2012
Journal Articles

Influence of Targeted Therapy in Redefining High-Risk Myeloma.

Lori Hazlehurst, PhD, William S. Dalton, MD, PhD, Danielle Yarde, Yulia Nefedova, MD, PhD, Dmitry Gabrilovich
Journal: Blood
Blood (2008) 112 (11): sci-7.
https://doi.org/10.1182/blood.V112.11.sci-7.sci-7
Published: 2008
Journal Articles

Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy

Yulia Nefedova, Daniel M. Sullivan, Sophia C. Bolick, William S. Dalton, Dmitry I. Gabrilovich
Journal: Blood
Blood (2008) 111 (4): 2220–2229.
https://doi.org/10.1182/blood-2007-07-102632
Published: 2008
Journal Articles

A New Target in Multiple Myeloma: Inhibition of Notch Pathway Induces Apoptosis and Enhances Drug Sensitivity of Myeloma Cells In Vitro and In Vivo.

Yulia Nefedova, MD, PhD, Krista Verali, Daniel M. Sullivan, MD, William S. Dalton, MD, PhD, Dmitry I. Gabrilovich, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 841.
https://doi.org/10.1182/blood.V108.11.841.841
Published: 2006
Journal Articles

Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands

Pingyan Cheng, Yulia Nefedova, Cesar A. Corzo, Dmitry I. Gabrilovich
Journal: Blood
Blood (2006) 109 (2): 507–515.
https://doi.org/10.1182/blood-2006-05-025601
Published: 2006
Includes: Supplemental data
Journal Articles

Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines

Yulia Nefedova, Pingyan Cheng, Melissa Alsina, William S. Dalton, Dmitry I. Gabrilovich
Journal: Blood
Blood (2004) 103 (9): 3503–3510.
https://doi.org/10.1182/blood-2003-07-2340
Published: 2004
Journal Articles

Notch signaling is necessary but not sufficient for differentiation of dendritic cells

Pingyan Cheng, Yulia Nefedova, Lucio Miele, Barbara A. Osborne, Dmitry Gabrilovich
Journal: Blood
Blood (2003) 102 (12): 3980–3988.
https://doi.org/10.1182/blood-2003-04-1034
Published: 2003